1[1]Jones RN. Ceftibuten: a review of antimicrobial activity, spectrum amd other microbiologic features. Pediatr Infect Dis J, 1993,12: 37 - 44. 被引量：1
2[2]Jones RN. Antimicrobial activity and spectrum of ceftibuten, a review, of United States and Canadian results. Diagn Microbiol Infect Dis, 1991,14:37 - 43. 被引量：1
3[3]Wiseman LR, Balfour JA. Ceftibuten: a review of its antibacterial activity,Pharmacokinetic Properties and clincal efficacy. Dnugs, 1994,47:784 - 808. 被引量：1
4[4]Wise R, Andrews JM, Ashby JP, et al. Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom. Diagn Microbiol Infect Dis, 1991,14:45 - 52. 被引量：1
5[5]Barr WH, Lin CC, Radwanski E, et al. The pharmacokinetics of ceftibuten in humans. Diagn Microbiol Infect Dis, 1991,14:93 - 100. 被引量：1
6[6]McCake R, Rumans L, Perrotta R, et al. Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis. J Chemother, 1993,5:124 - 132. 被引量：1
7[7]Reidenberg BE. Worldwide safety experience with ceftibuten paediatric suspension. Pediatr Infect Dis J, 1995,14: 5130 - 5133. 被引量：1
